INNO-206 in Patients With Small Cell Lung Cancer (SCLC)

Status:
Withdrawn

Trial end date:
2008-11-01

Target enrollment:

Participant gender:

The purpose of this study is to determine whether INNO-206 is effective in the treatment of small cell lung cancer.

Phase 2

CytRx